Steven M Shamah

This inventor holds 12 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Juno Therapeutics Gmbh, X-Body, Inc., Memorial Sloan Kettering Cancer Center. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven M Shamah. Retrieved from https://idiyas.com/inventor/steven-m-shamah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 23(Granted Patents)

Location History:

Waltham, MA (US) (2019 - 2022)
Acton, MA (US) (2020 - 2023)
Seattle, WA (US) (2021 - 2024)

Company Filing History:

7 out of 77

Juno Therapeutics Gmbh

Memorial Sloan Kettering Cancer Center

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12674000 - ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19 (2026-07-07),

2. 12428486 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2025-09-30),

3. 11919970 - Antibodies and chimeric antigen receptors specific for ROR1 (2024-03-05),

4. 11827714 - Antibodies and chimeric antigen receptors specific for CD19 (2023-11-28),

5. 11623961 - Antibodies and chimeric antigen receptors specific for B-cell maturation antigen (2023-04-11),

6. 11414784 - Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes (2022-08-16),

7. 11339388 - Methods and compositions for generation of binding agents against cell surface antigens (2022-05-24),

8. 11066475 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2021-07-20),

9. 10889652 - Antibodies and chimeric antigen receptors specific for ROR1 (2021-01-12),

10. 10533055 - Antibodies and chimeric antigen receptors specific for CD19 (2020-01-14),

11. 10519436 - Methods and compositions for generation of binding agents against cell surface antigens (2019-12-31),

12. 10370651 - Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes (2019-08-06),

Title: The Innovative Journey of Steven M Shamah

Introduction: Steven M Shamah is a prolific inventor based in Waltham, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Steven M Shamah holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Steven M Shamah has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have made a significant impact in the industry.

Collaborations: Throughout his career, Steven M Shamah has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: Steven M Shamah's relentless pursuit of innovation and his passion for creating solutions that make a difference have solidified his reputation as a visionary inventor in Waltham, MA.

Profile summary based on public USPTO records.